KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Aquestive Therapeutics (AQST) Return on Equity: 2018-2025

Historic Return on Equity for Aquestive Therapeutics (AQST) over the last 7 years, with Sep 2025 value amounting to 1.80%.

  • Aquestive Therapeutics' Return on Equity rose 93.00% to 1.80% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.80%, marking a year-over-year increase of 93.00%. This contributed to the annual value of 0.53% for FY2024, which is 46.00% up from last year.
  • As of Q3 2025, Aquestive Therapeutics' Return on Equity stood at 1.80%, which was up 84.62% from 0.97% recorded in Q2 2025.
  • In the past 5 years, Aquestive Therapeutics' Return on Equity ranged from a high of 1.80% in Q3 2025 and a low of 0.08% during Q4 2023.
  • For the 3-year period, Aquestive Therapeutics' Return on Equity averaged around 0.65%, with its median value being 0.72% (2024).
  • As far as peak fluctuations go, Aquestive Therapeutics' Return on Equity slumped by 397bps in 2021, and later skyrocketed by 93bps in 2025.
  • Over the past 5 years, Aquestive Therapeutics' Return on Equity (Quarterly) stood at 0.99% in 2021, then tumbled by 51bps to 0.48% in 2022, then plummeted by 41bps to 0.08% in 2023, then skyrocketed by 76bps to 0.84% in 2024, then surged by 93bps to 1.80% in 2025.
  • Its last three reported values are 1.80% in Q3 2025, 0.97% for Q2 2025, and 0.90% during Q1 2025.